Article

An American Journal of Managed Care Medical Crossfire: Management of Newer Ultra-Long Acting Basal Insulin Agents in Diabetes

https://www.pharmacytimes.org/landing/1139

https://www.pharmacytimes.org/landing/1139

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Related Content
Methotrexate box | Image credit: DenisMArt – stock.adobe.com
September 4th 2025

Methotrexate May Lower Blood Pressure in Rheumatoid Arthritis

Hayden E. Klein
Managed Care Cast Logo
September 4th 2025

AI in Health Care: Balancing Governance, Innovation, and Trust

Maggie L. Shaw Reuben Daniel
BRCA | Image Credit: syahrir - stock.adobe.com
September 4th 2025

Economic Burden Is Greater Among Patients With Ovarian Cancer Receiving BRCA Testing

Brooke McCormick
managed care cast logo
September 4th 2025

Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA

Brooke McCormick Richard A. Brook, MS, MBA
CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
September 4th 2025

CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges

Capitol hill | Image credit: MarketingShotz - stock.adobe.com
September 4th 2025

Kennedy Defends HHS Decisions in Senate Finance Committee Hearing

Julia Bonavitacola

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo